Search results
Philip Newsome is Honorary Professor of Experimental Hepatology and was Director of the Centre for Liver and Gastrointestinal Research. He was also Director of the Innovate-UK funded Midlands and Wales Advanced Therapy Treatment Centre.
Sep 30, 2024 · Photoacoustic imaging could give us much more detailed information to facilitate early diagnosis, as well as better understand disease progression more generally.” Dr Plumb is also Associate Professor of Medical Imaging at UCL.
Oct 16, 2024 · Pictures that speak a thousand words. A new project will see researchers, surgeons and engineers use AI to generate incredible insights from biological scans and histological stains. We caught up with co-lead Professor Joanne Edwards to talk radiomics, stratification and potential patient impact….
Jun 1, 2023 · Getty Images. A blood test for more than 50 types of cancer has shown real promise in a major NHS trial, researchers say. The test correctly revealed two out of every three cancers among 5,000...
- What’s Changing?
- Why Do The Old Targets Need to Be Replaced?
- A More Ambitious Trajectory
There are currently 9 separate performance standards for cancer. The standards aim to streamline the current existing targets into 3 key targets: 1. The 28-day FDS – People who have been urgently referred for suspected cancer, have breast symptoms, or have been picked up through cancer screening, have cancer ruled out or receive a diagnosis within ...
Right now, a key target is for people with suspected cancer to see a specialist within 14 days of being urgently referred by their GP or a screening programme, often referred to as the 2WW target. However, this doesn’t set expectations for how long someone will wait to have any tests they need, for the test results to come back, and for them to be ...
Cancer that’s diagnosed at an early stage, when it isn’t too large and hasn’t spread, is more likely to be treated successfully. This is why committing to ambitious targets for the time it takes for cancer to be diagnosed is so important. While the FDS is a step in the right direction, in the longer term we hope that NHS England will set the FDS on...
Jul 15, 2024 · Mr Balwinder Singh, 58 years old, from Bedford is one patient whose treatment and wellbeing has been transformed following whole genome sequencing. After starting chemotherapy for an aggressive form of soft tissue sarcoma cancer in September 2022, his disease progressed.
People also ask
What will professor Newsome do for Hepatology?
Who is Professor Newsome?
Who is Philip Newsome?
Who supports cancer research?
Feb 28, 2024 · Professor Newsome’s leadership will be pivotal in uniting the strong clinical academic expertise in hepatology of three significant institutions: The Roger Williams Institute of Hepatology, King’s College London and King’s College Hospital NHS Foundation Trust (KCH).
8.0/10 (17320 reviews)
Get Accurate Answers To Your Medical Questions By Verified Doctors. Certified & Verified Doctors Will Answer All Your Medical Questions
A+ Rating - Better Business Bureau
Research that pushes the boundaries of cancer care. Features original cancer research, brief reports, and case studies
